Mitochondrial metabolism as a target for cancer therapy
K Vasan, M Werner, NS Chandel - Cell metabolism, 2020 - cell.com
Recent evidence in humans and mice supports the notion that mitochondrial metabolism is
active and necessary for tumor growth. Mitochondrial metabolism supports tumor anabolism …
active and necessary for tumor growth. Mitochondrial metabolism supports tumor anabolism …
Metabolic reprogramming and cancer progression
BACKGROUND Metabolic reprogramming is a hallmark of malignancy first recognized a
century ago. In some cases, reprogrammed metabolic activities can be exploited to …
century ago. In some cases, reprogrammed metabolic activities can be exploited to …
[HTML][HTML] Mitochondrial Sirtuin 3: New emerging biological function and therapeutic target
J Zhang, H Xiang, J Liu, Y Chen, RR He, B Liu - Theranostics, 2020 - ncbi.nlm.nih.gov
Abstract Sirtuin 3 (SIRT3) is one of the most prominent deacetylases that can regulate
acetylation levels in mitochondria, which are essential for eukaryotic life and inextricably …
acetylation levels in mitochondria, which are essential for eukaryotic life and inextricably …
Mitochondrial ubiquinol oxidation is necessary for tumour growth
I Martínez-Reyes, LR Cardona, H Kong, K Vasan… - Nature, 2020 - nature.com
The mitochondrial electron transport chain (ETC) is necessary for tumour growth,,,,–and its
inhibition has demonstrated anti-tumour efficacy in combination with targeted therapies …
inhibition has demonstrated anti-tumour efficacy in combination with targeted therapies …
Mammalian SWI/SNF chromatin remodeling complexes: emerging mechanisms and therapeutic strategies
RC Centore, GJ Sandoval, LMM Soares, C Kadoch… - Trends in Genetics, 2020 - cell.com
Small molecule-based targeting of chromatin regulatory factors has emerged as a promising
therapeutic strategy in recent years. The development and ongoing clinical evaluation of …
therapeutic strategy in recent years. The development and ongoing clinical evaluation of …
Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy
JL Carter, K Hege, J Yang, HA Kalpage, Y Su… - Signal transduction and …, 2020 - nature.com
Acute myeloid leukemia (AML) is the most common form of acute leukemia in adults and the
second most common form of acute leukemia in children. Despite this, very little …
second most common form of acute leukemia in children. Despite this, very little …
The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML
For two decades, leukaemia stem cells (LSCs) in chronic myeloid leukaemia (CML) and
acute myeloid leukaemia (AML) have been advanced paradigms for the cancer stem cell …
acute myeloid leukaemia (AML) have been advanced paradigms for the cancer stem cell …
Altered cellular metabolism in gliomas—An emerging landscape of actionable co-dependency targets
Altered cellular metabolism is a hallmark of gliomas. Propelled by a set of recent
technological advances, new insights into the molecular mechanisms underlying glioma …
technological advances, new insights into the molecular mechanisms underlying glioma …
Bone marrow mesenchymal stem cells support acute myeloid leukemia bioenergetics and enhance antioxidant defense and escape from chemotherapy
D Forte, M García-Fernández, A Sanchez-Aguilera… - Cell metabolism, 2020 - cell.com
Like normal hematopoietic stem cells, leukemic stem cells depend on their bone marrow
(BM) microenvironment for survival, but the underlying mechanisms remain largely …
(BM) microenvironment for survival, but the underlying mechanisms remain largely …
[HTML][HTML] Accumulation of long-chain fatty acids in the tumor microenvironment drives dysfunction in intrapancreatic CD8+ T cells
CD8+ T cells are master effectors of antitumor immunity, and their presence at tumor sites
correlates with favorable outcomes. However, metabolic constraints imposed by the tumor …
correlates with favorable outcomes. However, metabolic constraints imposed by the tumor …